Ultrasmall superparamagnetic particles of iron oxide allow for the detection of metastases in normal sized pelvic lymph nodes of patients with bladder and/or prostate cancer

European Journal of Cancer

Volumn 49, Issue 3, 2013, Pages 616-624

  Triantafyllou, Maria ^a   Studer, Urs E ^a   Birkhäuser, Frédéric D ^a   Fleischmann, Achim ^a   Bains, Lauren J ^a   Petralia, Giuseppe ^a   Christe, Andreas ^a   Froehlich, Johannes M ^a   Thoeny, Harriet C ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bladder cancer; Histopathology; Lymph nodes; Metastases; MRI; Prostate cancer; Surgery; USPIO

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

ADULT; AGED; ARTICLE; BLADDER CANCER; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIARRHEA; DRUG WITHDRAWAL; DYSPNEA; FEMALE; HISTOPATHOLOGY; HOT FLUSH; HUMAN; HUMAN TISSUE; HYPERTENSION; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS LYMPH NODE; POSTOPERATIVE PERIOD; PREDICTIVE VALUE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; RADIODIAGNOSIS; SENSITIVITY AND SPECIFICITY; URTICARIA;

ADULT; AGED; CONTRAST MEDIA; DEXTRANS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; URINARY BLADDER NEOPLASMS;

EID: 84872686280     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.09.034     Document Type: Article

References (29)

1. P.C. Walsh Surgery and the reduction of mortality from prostate cancer N Engl J Med 347 2002 839 840
2. E.M. Messing, J. Manola, M. Sarosdy, G. Wilding, E.D. Crawford, and D. Trump Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer N Engl J Med 341 1999 1781 1788
3. L. Holmberg, A. Bill-Axelson, and F. Helgesen A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer N Engl J Med 347 2002 781 789
4. V. Pagliarulo, D. Hawes, and F.H. Brands Detection of occult lymph node metastases in locally advanced node-negative prostate cancer J Clin Oncol 24 2006 2735 2742
5. M.C. Schumacher, F.C. Burkhard, G.N. Thalmann, A. Fleischmann, and U.E. Studer Good outcome for patients with few lymph node metastases after radical retropubic prostatectomy Eur Urol 54 2008 344 352
6. F.C. Burkhard, B. Roth, P. Zehnder, and U.E. Studer Lymphadenectomy for bladder cancer: indications and controversies Urol Clin North Am 38 2011 397 405
7. P. Zehnder, U.E. Studer, and E.C. Skinner Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study J Urol 186 2011 1261 1268
8. A. Briganti, P. Rigatti, and F. Montorsi The importance of the extent of pelvic-lymph-node dissection in the diagnosis of lymph-node-metastases in prostate cancer Lancet Oncol 9 2008 915 917
9. A. Fleischmann, G.N. Thalmann, R. Markwalder, and U.E. Studer Extracapsular extension of pelvic lymph node metastases from urothelial carcinoma of the bladder is an independent prognostic factor J Clin Oncol 23 2005 2358 2365
10. P. Bader, F.C. Burkhard, R. Markwalder, and U.E. Studer Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? J Urol 169 2003 849 854
11. A.P. McLaughlin, S.L. Saltzstein, D.L. McCullough, and R.F. Gittes Prostatic carcinoma: incidence and location of unsuspected lymphatic metastases J Urol 115 1976 89 94
12. B. Roth, M.P. Wissmeyer, and P. Zehnder A new multimodality technique accurately maps the primary lymphatic landing sites of the bladder Eur Urol 57 2010 205 211
13. D.G. Skinner Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference J Urol 128 1982 34 36
14. H. Herr, B. Konety, J. Stein, C.N. Sternberg, and D.P. Wood Jr. Optimizing outcomes at every stage of bladder cancer: do we practice it? Urol Oncol 27 2009 72 74
15. J.H. Sepherd Revised FIGO staging for gynaecological cancer Br J Obstet Gynaecol 96 1989 889 892
16. A. Briganti, M.L. Blute, and J.H. Eastham Pelvic lymph node dissection in prostate cancer Eur Urol 55 2009 1251 1265
17. Y. Anzai, C.W. Piccoli, and E.K. Outwater Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study Radiology 228 2003 777 788
18. M.G. Harisinghani, J. Barentsz, and P.F. Hahn Noninvasive detection of clinically occult lymph-node metastases in prostate cancer N Engl J Med 348 2003 2491 2499
19. A.G. Rockall, S.A. Sohaib, and M.G. Harisinghani Diagnostic performance of nanoparticle-enhanced magnetic resonance imaging in the diagnosis of lymph node metastases in patients with endometrial and cervical cancer J Clin Oncol 23 2005 2813 2821
20. R.A. Heesakkers, A.M. Hövels, and G.J. Jager MRI with a lymph-node-specific contrast agent as an alternative to CT scan and lymph-node dissection in patients with prostate cancer: a prospective multicohort study Lancet Oncol 9 2008 850 856
21. A.M. Hövels, R.A. Heesakkers, E.M. Adang, J.O. Barentsz, G.J. Jager, and J.L. Severens Cost-effectiveness of MR lymphography for the detection of lymph node metastases in patients with prostate cancer Radiology 252 2009 729 736
22. R. Weissleder, G. Elizondo, J. Wittenberg, A.S. Lee, L. Josephson, and T.J. Brady Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging Radiology 175 1990 494 498
23. M. Russell, and Y. Anzai Ultrasmall superparamagnetic iron oxide enhanced MR imaging for lymph node metastases Radiography 13 2007 e73 e84
24. M.F. Bellin, L. Lebleu, and J.B. Meric Evaluation of retroperitoneal and pelvic lymph node metastases with MRI and MR-lymphography Abdom Imaging 28 2003 155 163
25. --weighted MR imaging at 1.5 and 3.0 T: early experience Radiology 239 2006 481 487
26. W.M. Deserno, M.G. Harisinghani, and M. Taupitz Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imaging Radiology 233 2004 449 456
27. J.M. Froehlich, M. Triantafyllou, A. Fleischmann, P. Vermathen, G.N. Thalmann, and H.C. Thoeny Does quantification on USPIO related signal loss allow differentiation of benign and malignant normal sized pelvic lymph nodes? Contrast Media Mol Imaging 7 2012 346 355
28. Randolph JJ. Free-marginal multirater kappa: an alternative to Fleiss' fixed-marginal multirater kappa. In: Joensuu University Learning and Instruction Symposium, 2005 October 14-15, Joensuu, Finland.
29. M. Warrens Inequalities between multi-rater kappas Adv Data Anal Classif 4 2010 271 286